[
  {
    "ts": "2026-02-18T09:26:00+00:00",
    "headline": "Fallopian Tube Cancer Market Research Report 2026: AstraZeneca, GlaxoSmithKline, Pfizer and Roche Expand Portfolios and Invest in Novel Therapeutics & Companion Diagnostics - Forecasts 2025-2035",
    "summary": "Fallopian tube cancer, a rare gynecologic cancer, is gaining awareness due to its potential origin for many high-grade serous ovarian cancers. New diagnostics improve early detection and treatment, boosting patient outcomes. Symptoms are often subtle, leading to underdiagnosis and treatment delays. The fallopian tube cancer market is driven by genetic testing demand, BRCA mutation screening, and advancements in targeted therapies like PARP inhibitors. Despite challenges, including high treatment",
    "url": "https://finance.yahoo.com/news/fallopian-tube-cancer-market-research-092600660.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "6bf6abe8-13ab-3ffa-b94a-fbc329fb953f",
      "content": {
        "id": "6bf6abe8-13ab-3ffa-b94a-fbc329fb953f",
        "contentType": "STORY",
        "title": "Fallopian Tube Cancer Market Research Report 2026: AstraZeneca, GlaxoSmithKline, Pfizer and Roche Expand Portfolios and Invest in Novel Therapeutics & Companion Diagnostics - Forecasts 2025-2035",
        "description": "",
        "summary": "Fallopian tube cancer, a rare gynecologic cancer, is gaining awareness due to its potential origin for many high-grade serous ovarian cancers. New diagnostics improve early detection and treatment, boosting patient outcomes. Symptoms are often subtle, leading to underdiagnosis and treatment delays. The fallopian tube cancer market is driven by genetic testing demand, BRCA mutation screening, and advancements in targeted therapies like PARP inhibitors. Despite challenges, including high treatment",
        "pubDate": "2026-02-18T09:26:00Z",
        "displayTime": "2026-02-18T09:26:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc",
          "originalWidth": 480,
          "originalHeight": 58,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_MlAqEncKPaKK77zrkRGmQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 480,
              "height": 58,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/caWFqk489OEmv3xI33JamQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fallopian-tube-cancer-market-research-092600660.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fallopian-tube-cancer-market-research-092600660.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AZN"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "GSK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]